Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer

Fig. 5

The Kaplan–Meier curves for the progression-free survival rate of metastatic breast cancer patients stratified by the response on 18F-FLT-PET or 18F-FDG-PET after one or two cycles of chemotherapy. The metabolic responders on post-2c 18F-FDG-PET based on PERCIST showed a significantly higher survival rate than metabolic non-responders

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us